» Articles » PMID: 32585314

Recognition of Physiological Phosphorylation Sites by P21-activated Kinase 4

Overview
Journal J Struct Biol
Date 2020 Jun 26
PMID 32585314
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Many serine/threonine protein kinases discriminate between serine and threonine substrates as a filter to control signaling output. Among these, the p21-activated kinase (PAK) group strongly favors phosphorylation of Ser over Thr residues. PAK4, a group II PAK, almost exclusively phosphorylates its substrates on serine residues. The only well documented exception is LIM domain kinase 1 (LIMK1), which is phosphorylated on an activation loop threonine (Thr508) to promote its catalytic activity. To understand the molecular and kinetic basis for PAK4 substrate selectivity we compared its mode of recognition of LIMK1 (Thr508) with that of a known serine substrate, β-catenin (Ser675). We determined X-ray crystal structures of PAK4 in complex with synthetic peptides corresponding to its phosphorylation sites in LIMK1 and β-catenin to 1.9 Å and 2.2 Å resolution, respectively. We found that the PAK4 DFG + 1 residue, a key determinant of phosphoacceptor preference, adopts a sub-optimal orientation when bound to LIMK1 compared to β-catenin. In peptide kinase activity assays, we find that phosphoacceptor identity impacts catalytic efficiency but does not affect the K value for both phosphorylation sites. Although catalytic efficiency of wild-type LIMK1 and β-catenin are equivalent, T508S mutation of LIMK1 creates a highly efficient substrate. These results suggest suboptimal phosphorylation of LIMK1 as a mechanism for controlling the dynamics of substrate phosphorylation by PAK4.

Citing Articles

Regulation and signaling of the LIM domain kinases.

Casanova-Sepulveda G, Boggon T Bioessays. 2024; 47(1):e2400184.

PMID: 39361252 PMC: 11663136. DOI: 10.1002/bies.202400184.


Rho family GTPase signaling through type II p21-activated kinases.

Chetty A, Ha B, Boggon T Cell Mol Life Sci. 2022; 79(12):598.

PMID: 36401658 PMC: 10105373. DOI: 10.1007/s00018-022-04618-2.


Molecular basis for integrin adhesion receptor binding to p21-activated kinase 4 (PAK4).

Ha B, Yigit S, Natarajan N, Morse E, Calderwood D, Boggon T Commun Biol. 2022; 5(1):1257.

PMID: 36385162 PMC: 9669019. DOI: 10.1038/s42003-022-04157-3.


Structural Aspects of LIMK Regulation and Pharmacology.

Chatterjee D, Preuss F, Dederer V, Knapp S, Mathea S Cells. 2022; 11(1).

PMID: 35011704 PMC: 8750758. DOI: 10.3390/cells11010142.


The Role of p21-Activated Kinases in Cancer and Beyond: Where Are We Heading?.

Liu H, Liu K, Dong Z Front Cell Dev Biol. 2021; 9:641381.

PMID: 33796531 PMC: 8007885. DOI: 10.3389/fcell.2021.641381.

References
1.
Turk B . Understanding and exploiting substrate recognition by protein kinases. Curr Opin Chem Biol. 2008; 12(1):4-10. PMC: 2366800. DOI: 10.1016/j.cbpa.2008.01.018. View

2.
Kumar R, Sanawar R, Li X, Li F . Structure, biochemistry, and biology of PAK kinases. Gene. 2016; 605:20-31. PMC: 5250584. DOI: 10.1016/j.gene.2016.12.014. View

3.
Guo Q, Su N, Zhang J, Li X, Miao Z, Wang G . PAK4 kinase-mediated SCG10 phosphorylation involved in gastric cancer metastasis. Oncogene. 2013; 33(25):3277-87. DOI: 10.1038/onc.2013.296. View

4.
Chen C, Ha B, Thevenin A, Lou H, Zhang R, Yip K . Identification of a major determinant for serine-threonine kinase phosphoacceptor specificity. Mol Cell. 2013; 53(1):140-7. PMC: 3898841. DOI: 10.1016/j.molcel.2013.11.013. View

5.
Otwinowski Z, Minor W . Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997; 276:307-26. DOI: 10.1016/S0076-6879(97)76066-X. View